Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Credit Suisse Outlines Top Biotech M&A Targets and Catalyst Stocks for 2018

Get ready for more mergers and acquisitions in biotech and in emerging pharmaceuticals in 2018. This theme is believed by many investors, and now Credit Suisse is touting that tax ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BofA, Honeywell, IBM, Lululemon, Oracle, United Tech, Wells Fargo and Many More

Stocks did not deviate from hitting all-time highs on the first trading day of the year, and the second trading day of the year is looking positive as well. The ...
Read Full Story »

Did You Just Miss the Launch of the US-Listed Marijuana ETF?

The first trading session after Christmas is almost always a quiet one, and the market is likely to remain quiet until after the start of 2018. The news flow from companies ...
Read Full Story »

Why Arena Pharmaceuticals Is Knocking It Out of the Park

Shares of Arena Pharmaceuticals Inc. (NASDAQ: ARNA) saw an incredible gain early Tuesday after the company reported positive results from its mid-stage trial in patients with pulmonary arterial hypertension (PAH). ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess, Western Digital and More

Stocks were indicated to open marginally lower on Tuesday, with no real pull from major news one way or the other. The bull market is now well over eight years ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, Enterprise Products, GrubHub, Mattel, Ryanair, Splunk and Many More

Stocks were indicated to open lower on Thursday after the markets hit new highs again on Wednesday, a day after the Federal Reserve hiked rates and announced a sooner than ...
Read Full Story »

Huge Transport Trade Highlights Insider Buying: CSX, GE, Mattel, IFF and More

With first-quarter earnings winding down, but still in the process, the windows for insiders remain closed for the most part, so we had another week of lower volumes. However, with ...
Read Full Story »

Valeant, Arena Pharmaceuticals in Tuesday’s 52-Week Low Club

April 18, 2017: Here are four stocks trading with relatively heavy volume among 85 equities making new 52-week lows in Tuesday's session. On the NYSE, decliners led advancers by about ...
Read Full Story »

Arena Pharmaceuticals Sinks After Announcing Secondary Offering

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) saw its shares drop sharply on Tuesday after the company announced a secondary offering. Arena plans to offer 60 million shares of its common stock ...
Read Full Story »

Wednesday’s Biggest Biopharma Movers

The broad markets inched forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) was up ...
Read Full Story »
Woman holding hemp flowers, Marijuana plant, weed

The 10 Largest Marijuana Companies

The November election wound up with eight states added to the number of them where either medical or recreational marijuana (or both) are or will be legally for sale. Medical marijuana ...
Read Full Story »
biotech word cloud

Top 6 BioPharma Movers of the Week

Over the past week, a few biotech companies made absolutely massive runs. In the past year, the health care sector was on fire from positive trials, U.S. Food and Drug ...
Read Full Story »

Arena Pharma Soars on FDA Approval

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) saw its shares jump in Monday’s session on news of an U.S. Food and Drug Administration (FDA) approval. The company announced that the FDA has ...
Read Full Story »
buy sell

5 Stocks That Should See Huge Buying on Russell Month-End Index Changes

All the major indexes rebalance share weightings on a regular basis, as price and market cap changes dictate either buying or selling of shares at a designated time. This Friday ...
Read Full Story »

Credit Suisse Positive on Some Biotechs, Very Cautious on Others

Credit Suisse has launched new biotech coverage on Wednesday with two analysts at the firm. The biotech sector has been a wealth-creation engine in recent years. What is interesting here ...
Read Full Story »